Protalix BioTherapeutics
PLX
#8915
Rank
A$0.20 B
Marketcap
A$2.60
Share price
-1.14%
Change (1 day)
-1.37%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2025 (TTM): A$13.98 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are A$61.94 Million. In 2024 the company made an earning of A$7.85 Million a decrease over its 2023 earnings that were of A$17.69 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$13.98 M78.11%
2024 A$7.85 M-55.62%
2023 A$17.69 M-199.05%
2022 -A$17.87 Million-40.38%
2021 -A$29.97 Million-732.31%
2020 A$4.73 M-130.53%
2019 -A$15.53 Million189.85%
2018 -A$5.36 Million-95.29%
2017 -A$0.12 Billion308.12%
2016 -A$27.87 Million-32.37%
2015 -A$41.21 Million10.11%
2014 -A$37.43 Million-7.59%
2013 -A$40.5 Million
2011 -A$46.9 Million-19.39%
2010 -A$58.18 Million20.87%
2009 -A$48.13 Million32.26%
2008 -A$36.39 Million-5.46%
2007 -A$38.5 Million
2004 -A$0.25 Million12.35%
2003 -A$0.23 Million-11.1%
2002 -A$0.25 Million-57.03%
2001 -A$0.59 Million1.03%
2000 -A$0.58 Million-53.22%
1999 -A$1.23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amicus Therapeutics
FOLD
A$7.5 M-45.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$0.87 B 6,251.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.84 B 128,978.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$2.66 B 19,198.63%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel